Search
Close this search box.
Search
Close this search box.

MENA

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the pricing of its upsized initial public offering of 13,235,294 shares of its common stock

Read More

Guided by Customer-Centric Philosophy, VinFast Navigates New EV Realities

VinFast is responding to the evolving electric vehicle (EV) market with a customer-centric philosophy focused on affordability, quality, and comprehensive after-sales support. This is reflected in its diverse model range and expansion into emerging markets, positioning the company for sustained growth. HANOI, VIETNAM – Media OutReach Newswire -12 September 2024

Read More